Variant report
Variant | nsv970049 |
---|---|
Chromosome Location | chr6:86395496-86410652 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:86396233..86399301-chr6:86399651..86402841,3 | MCF-7 | breast: | |
2 | chr6:86397570..86400477-chr6:86416259..86418684,2 | K562 | blood: | |
3 | chr6:86396233..86399301-chr6:86399651..86402841,3 | MCF-7 | breast: | |
4 | chr6:86352687..86354772-chr6:86394800..86396711,3 | MCF-7 | breast: | |
5 | chr6:86398204..86400285-chr6:86400483..86402963,2 | K562 | blood: | |
6 | chr6:86385642..86390131-chr6:86401946..86405248,5 | K562 | blood: | |
7 | chr6:86387116..86389313-chr6:86395137..86397697,2 | MCF-7 | breast: | |
8 | chr6:86392546..86395306-chr6:86396739..86401474,7 | K562 | blood: | |
9 | chr6:86398204..86400285-chr6:86400483..86402963,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000203875 | chromatin interactions |
ENSG00000135316 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530911114 | chr6:86395540-86395541 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs141418133 | chr6:86395544-86395545 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs150817992 | chr6:86395557-86395558 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs567600129 | chr6:86395568-86395569 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs547078512 | chr6:86395570-86395571 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs565694109 | chr6:86395683-86395684 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs192361776 | chr6:86395699-86395700 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs185727414 | chr6:86395700-86395701 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs554435623 | chr6:86395706-86395707 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs569652344 | chr6:86395707-86395708 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs536629971 | chr6:86395713-86395714 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs115113921 | chr6:86395731-86395732 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs116721099 | chr6:86395745-86395746 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs372177701 | chr6:86395780-86395781 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs540729445 | chr6:86395919-86395920 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs536727486 | chr6:86395928-86395929 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs139634524 | chr6:86395956-86395957 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs149755054 | chr6:86395986-86395987 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs563949610 | chr6:86396047-86396048 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs531199962 | chr6:86396099-86396100 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs78823741 | chr6:86396116-86396117 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs546533823 | chr6:86396129-86396130 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs554055651 | chr6:86396229-86396230 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs564430024 | chr6:86396247-86396248 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs528486914 | chr6:86396299-86396300 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs553084238 | chr6:86396301-86396302 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs568582581 | chr6:86396302-86396303 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs529835918 | chr6:86396336-86396337 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs113880975 | chr6:86396348-86396349 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs566638313 | chr6:86396349-86396350 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs188991570 | chr6:86396371-86396372 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs367940372 | chr6:86396429-86396430 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs372242865 | chr6:86396467-86396468 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs558439461 | chr6:86396521-86396522 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs570349481 | chr6:86396552-86396553 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs139353938 | chr6:86396582-86396583 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs181085137 | chr6:86396583-86396584 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs117455343 | chr6:86396593-86396594 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs541966435 | chr6:86396690-86396691 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs557552757 | chr6:86396696-86396697 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs186323373 | chr6:86396728-86396729 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs575915872 | chr6:86396731-86396732 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs546470429 | chr6:86396753-86396754 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs564848580 | chr6:86396763-86396764 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs369586826 | chr6:86396814-86396815 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs117893175 | chr6:86396827-86396828 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs79669975 | chr6:86396879-86396880 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs4707217 | chr6:86396932-86396933 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs372510507 | chr6:86396941-86396942 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs529362034 | chr6:86396944-86396945 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:86394600-86395800 | Enhancers | Psoas Muscle | Psoas |
2 | chr6:86395200-86395800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
3 | chr6:86395200-86396000 | Flanking Active TSS | GM12878-XiMat | blood |
4 | chr6:86395400-86395800 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
5 | chr6:86395400-86395800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
6 | chr6:86395800-86399200 | Weak transcription | Psoas Muscle | Psoas |
7 | chr6:86396000-86396200 | Enhancers | GM12878-XiMat | blood |
8 | chr6:86410600-86414800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |